There has been an explosion of data demonstrating an increased risk for non–diabetic kidney disease among relatives of patients with end-stage renal disease (ESRD); please refer to eAJKD interview with Dr. Barry Freedman [1-4]. The increased risk [read more...]
Commentaries are short perspectives by experts on AJKD articles or nephrology news.
Invited Commentary by Dr. Surya Seshan Minimal change disease (MCD) is the most common cause of steroid-responsive glomerular disease with selective proteinuria. A number of animal models (induced by puromycin, protamine sulfate, etc) were developed [read more...]
Invited commentary by Dr. Steven Fishbane and Azzour Hazzan In the Jan 2012 issue of the AJKD, Fukuma et al conducted an elegant analysis of ESA dose and hemoglobin (Hgb) concentration as predictors of patient outcomes, even after adjusting for [read more...]
Interest in nephrology amongst US medical graduates has been steadily decreasing since 2002. This might not be so worrisome if the number of kidney patients was remaining the same. Unfortunately, the burden of kidney disease in America increases [read more...]
Invited Commentary by Dr. Lionel Mailloux It is interesting to note the two recent articles in the American Journal of Kidney Diseases on the topic of home hemodialysis. One was by Marshall et al entitled “Home Hemodialysis and Mortality Risk in [read more...]